Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Knock-in mouse model with labeled insulin provides essential tool for diabetes research and drug development


Summary

Argiris Efstratiadis, Ph.D.


Technology Benefits

Directly labels insulin in vivo such that the GFP is restricted only to the cells where insulin is foundAll regulatory elements in the insulin gene are kept intact, so expression can’t be falsely altered by other local factors (like in transgenic mice) Any genetic or environment modifications to the endogenous insulin will be accurately represented by the GFP labelPatent information:Patent PendingTech Ventures Reference: IR 2363


Technology Application

Animal model to investigate genetic and environmental factors that cause insulin level and expression changes Ability to track insulin production and secretion will provide insight into effectiveness of various drug compounds for diabetes treatmentFurther in vivo investigation into insulin-secreting beta cells, which are labeled by the GFPThe labeling of cells that interact with insulin will allow precise extraction of these cells for ex vivo experimentsIdentification of novel proteins that interact with insulin, which may serve as therapeutic targets for diabetes


Detailed Technology Description

Argiris Efstratiadis, Ph.D.


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View